A broad-spectrum LC-MS/MS method for screening and quantification of 100 analytes in clinical and autopsy blood samples.

Blood Drugs Forensic toxicology LC-MS/MS NPS

Journal

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
ISSN: 1873-376X
Titre abrégé: J Chromatogr B Analyt Technol Biomed Life Sci
Pays: Netherlands
ID NLM: 101139554

Informations de publication

Date de publication:
18 Sep 2024
Historique:
received: 27 06 2024
revised: 13 09 2024
accepted: 15 09 2024
medline: 22 9 2024
pubmed: 22 9 2024
entrez: 22 9 2024
Statut: aheadofprint

Résumé

Liquid chromatography coupled with mass spectrometry (LC-MS) has been tremendously used for screening purposes in forensic toxicology, because of their great adaptability and reasonable time/resource consumption. Herein, a fully validated method based on liquid-liquid extraction (LLE) in human whole blood, by a multiple reaction monitoring (MRM) analysis through LC-MS/MS, is described. The proposed method simultaneously detects 100 analytes (plus three deuterated internal standard compounds) belonging to many different classes, including drugs of abuse, prescription and over-the-counter drugs commonly involved in poisoning and medical malpractice cases in our territory, as well as certain new psychoactive substances (NPS) and toxic substances potentially associated with adverse effects. The optimised LLE employs one extraction step of 200 μL blood using 0.1 M HCl methyl-tert-butyl-ether (MTBE) (acidified with concentrated HCl) proved to be suitable for the extraction of basic and neutral substances; as a reconstitution solvent a mixture of 88:12v/v, 0.1 % formic acid in 10 mM aqueous ammonium acetate, pH 3.5: 0.1 % formic acid in acetonitrile was used, yielding satisfactory recoveries for all analytes. The method was sensitive, showing low LOD/ LOQ for all substances ranging from 0.01 to 5/ 0.05-20 ng/mL, respectively. Linearity ranged between 0.05-500 ng/mL (R

Identifiants

pubmed: 39306869
pii: S1570-0232(24)00332-5
doi: 10.1016/j.jchromb.2024.124323
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

124323

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Dimitra Florou (D)

Department of Forensic Medicine and Toxicology, Faculty of Medicine, School of Health Sciences, University of Ioannina, University Campus, Ioannina 45500, Greece.

Mathew Di Rago (M)

Victorian Institute of Forensic Medicine-Toxicology, 65 Kavanagh St, Southbank, Melbourne, Victoria 3006, Australia; Department of Forensic Medicine, Monash University, Melbourne, Victoria 3006, Australia.

Amvrosios Orfanidis (A)

Department of Forensic Medicine and Toxicology, Faculty of Medicine, School of Health Sciences, University of Ioannina, University Campus, Ioannina 45500, Greece; University Hospital of Ioannina, Ioannina 45110, Greece.

Dimitri Gerostamoulos (D)

Victorian Institute of Forensic Medicine-Toxicology, 65 Kavanagh St, Southbank, Melbourne, Victoria 3006, Australia; Department of Forensic Medicine, Monash University, Melbourne, Victoria 3006, Australia.

Vassiliki A Boumba (VA)

Department of Forensic Medicine and Toxicology, Faculty of Medicine, School of Health Sciences, University of Ioannina, University Campus, Ioannina 45500, Greece; University Hospital of Ioannina, Ioannina 45110, Greece. Electronic address: vboumba@uoi.gr.

Classifications MeSH